Results for tag: "Arteriovenous Malformations Drug"

The Arteriovenous Malformations Drug market is a subset of the Cardiovascular Drugs market. It is composed of drugs used to treat arteriovenous malformations (AVMs), which are abnormal connections between arteries and veins. These connections can cause a variety of symptoms, including seizures, headaches, and stroke. Treatment options for AVMs include medications, surgery, and radiation therapy. The Arteriovenous Malformations Drug market is highly competitive, with a number of companies offering products to treat AVMs. These companies include Pfizer, Novartis, Merck, and Sanofi. Other companies in the market include Bayer, GlaxoSmithKline, and AstraZeneca. These companies are constantly developing new drugs and treatments to improve the quality of life for those suffering from AVMs. Show Less Read more